Mechanisms of epigenetic and cell-type specific regulation of Hey target genes in ES cells and cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 79, Issue , 2015, Pages 79-88

  Weber, David ^a   Heisig, Julia ^a   Kneitz, Susanne ^a   Wolf, Elmar ^a   Eilers, Martin ^a,b   Gessler, Manfred ^a,b,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cardiomyocyte differentiation; Epigenetic regulation; Notch signaling; Transcriptional repression

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HEY1 PROTEIN; HEY2 PROTEIN; HISTONE DEACETYLASE; JAGGED1; PEPTIDES AND PROTEINS; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; HEY1 PROTEIN, MOUSE; HEY2 PROTEIN, MOUSE; HISTONE; HISTONE DEACETYLASE INHIBITOR; HOMEODOMAIN PROTEIN; NKX2-5 PROTEIN, MOUSE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ADULT; ANIMAL CELL; ARTICLE; BCL11A GENE; BINDING SITE; CONTROLLED STUDY; CXCR4 GENE; DEACETYLATION; DOWN REGULATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE; GENE ACTIVITY; GENE OVEREXPRESSION; GENE REPRESSION; HEART MUSCLE CELL; HISTONE ACETYLATION; IN VITRO STUDY; JAG1 GENE; KRT7 GENE; MURINAE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION SITE; UPREGULATION; ZFHX3 GENE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; PIG; PROTEIN PROCESSING;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE; DOWN-REGULATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HOMEODOMAIN PROTEINS; MICE; MYOCYTES, CARDIAC; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SUS SCROFA; TRANSCRIPTION FACTORS;

EID: 84913573573     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.11.004     Document Type: Article

References (48)

1. Leimeister C., Externbrink A., Klamt B., Gessler M. Hey genes: a novel subfamily of hairy- and Enhancer of split related genes specifically expressed during mouse embryogenesis. Mech Dev 1999, 85:173-177.
2. Nakagawa O., Nakagawa M., Richardson J.A., Olson E.N., Srivastava D. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev Biol 1999, 216:72-84.
3. Fischer A., Steidl C., Wagner T.U., Lang E., Jakob P.M., Friedl P., et al. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 2007, 100:856-863.
4. Sakata Y., Kamei C.N., Nakagami H., Bronson R., Liao J.K., Chin M.T. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A 2002, 99:16197-16202.
5. Gessler M., Knobeloch K.P., Helisch A., Amann K., Schumacher N., Rohde E., et al. Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2-/- mice. Curr Biol 2002, 12:1601-1604.
6. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 2004, 18:901-911.
7. Kokubo H., Tomita-Miyagawa S., Hamada Y., Saga Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 2007, 134:747-755.
8. Koibuchi N., Chin M.T. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circ Res 2007, 100:850-855.
9. Xin M., Small E.M., van Rooij E., Qi X., Richardson J.A., Srivastava D., et al. Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc Natl Acad Sci U S A 2007, 104:7975-7980.
10. Iso T., Sartorelli V., Poizat C., Iezzi S., Wu H.Y., Chung G., et al. HERP, a novel heterodimer partner of HES/E(spl) in Notch signaling. Mol Cell Biol 2001, 21:6080-6089.
11. Gould F., Harrison S.M., Hewitt E.W., Whitehouse A. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J Virol 2009, 83:6727-6738.
12. Takata T., Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun 2003, 301:250-257.
13. Kathiriya I.S., King I.N., Murakami M., Nakagawa M., Astle J.M., Gardner K.A., et al. Hairy-related transcription factors inhibit GATA-dependent cardiac gene expression through a signal-responsive mechanism. J Biol Chem 2004, 279:54937-54943.
14. Fischer A., Klattig J., Kneitz B., Diez H., Maier M., Holtmann B., et al. Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Mol Cell Biol 2005, 25:8960-8970.
15. Doi H., Iso T., Yamazaki M., Akiyama H., Kanai H., Sato H., et al. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler Thromb Vasc Biol 2005, 25:2328-2334.
16. Shirvani S., Xiang F., Koibuchi N., Chin M.T. CHF1/Hey2 suppresses SM-MHC promoter activity through an interaction with GATA-6. Biochem Biophys Res Commun 2006, 339:151-156.
17. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 2003, 9:767-778.
18. Zweigerdt R., Burg M., Willbold E., Abts H., Ruediger M. Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. Cytotherapy 2003, 5:399-413.
19. Krueger C., Danke C., Pfleiderer K., Schuh W., Jack H.M., Lochner S., et al. A gene regulation system with four distinct expression levels. J Gene Med 2006, 8:1037-1047.
20. Balciunas D., Wangensteen K.J., Wilber A., Bell J., Geurts A., Sivasubbu S., et al. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet 2006, 2:e169.
21. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25.
22. Anders S., Huber W. Differential expression analysis for sequence count data. Genome Biol 2010, 11:R106.
23. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
24. de Hoon M.J.L., Imoto S., Nolan J., Miyano S. Open source clustering software. Bioinformatics 2004, 20(9):1453-1454.
25. Saldanha A.J. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004, 20:3246-3248.
26. Heisig J., Weber D., Englberger E., Winkler A., Kneitz S., Sung W.K., et al. Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors. PLoS Genet 2012, 8:e1002728.
27. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008, 9:R137.
28. Salmon-Divon M., Dvinge H., Tammoja K., Bertone P. PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinforma 2010, 11:415.
29. Thorvaldsdottir H., Robinson J.T., Mesirov J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013, 14:178-192.
30. Ye T., Krebs A.R., Choukrallah M.A., Keime C., Plewniak F., Davidson I., et al. seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res 2011, 39:e35.
31. Veerla S., Ringner M., Hoglund M. Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs. BMC Genomics 2010, 11:145.
32. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
33. Maltsev V.A., Rohwedel J., Hescheler J., Wobus A.M. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 1993, 44:41-50.
34. Hartman M.E., Librande J.R., Medvedev I.O., Ahmad R.N., Moussavi-Harami F., Gupta P.P., et al. An optimized and simplified system of mouse embryonic stem cell cardiac differentiation for the assessment of differentiation modifiers. PLoS One 2014, 9:e93033.
35. ENCODE A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011, 9:e1001046.
36. He A., Kong S.W., Ma Q., Pu W.T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci U S A 2011, 108:5632-5637.
37. Montgomery R.L., Davis C.A., Potthoff M.J., Haberland M., Fielitz J., Qi X., et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 2007, 21:1790-1802.
38. Stefanovic S., Barnett P., van Duijvenboden K., Weber D., Gessler M., Christoffels V.M. GATA-dependent regulatory switches establish atrioventricular canal specificity during heart development. Nat Commun 2014, 5:3680.
39. Donovan J., Kordylewska A., Jan Y.N., Utset M.F. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 2002, 12:1605-1610.
40. Kokubo H., Miyagawa-Tomita S., Tomimatsu H., Nakashima Y., Nakazawa M., Saga Y., et al. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ Res 2004, 95:540-547.
41. Xiang F., Sakata Y., Cui L., Youngblood J.M., Nakagami H., Liao J.K., et al. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Am J Physiol Heart Circ Physiol 2006, 290:H1997-H2006.
42. Liu Y., Yu M., Wu L., Chin M.T. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload. Am J Physiol Heart Circ Physiol 2010, 298:H2082-H2092.
43. Cao Y., Yao Z., Sarkar D., Lawrence M., Sanchez G.J., Parker M.H., et al. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 2010, 18:662-674.
44. Nakagawa O., McFadden D.G., Nakagawa M., Yanagisawa H., Hu T., Srivastava D., et al. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci U S A 2000, 97:13655-13660.
45. McLeay R.C., Lesluyes T., Cuellar Partida G., Bailey T.L. Genome-wide in silico prediction of gene expression. Bioinformatics 2012, 28:2789-2796.
46. Karlic R., Chung H.R., Lasserre J., Vlahovicek K., Vingron M. Histone modification levels are predictive for gene expression. Proc Natl Acad Sci U S A 2010, 107:2926-2931.
47. Schueler M., Zhang Q., Schlesinger J., Tonjes M., Sperling S.R. Dynamics of Srf, p300 and histone modifications during cardiac maturation in mouse. Mol Biosyst 2012, 8:495-503.
48. Schlesinger J., Schueler M., Grunert M., Fischer J.J., Zhang Q., Krueger T., et al. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet 2011, 7:e1001313.